期刊文献+

阵发性心房颤动与隐源性脑卒中的研究进展 被引量:1

Research Progress of Paroxysmal Atrial Fibrillation and Cryptogenic Stroke
下载PDF
导出
摘要 阵发性心房颤动(PAF)是引起隐源性脑卒中(CS)的最常见心源性因素。随着心电检测技术的改善,远程动态监测、植入式心电监测、心电起搏器及电除颤仪等检测手段的出现使PAF的检出率得到显著提高,一些简单实用的临床评分也为PAF的诊断提供了辅助方法。此外,心房颤动持续时间及发作频率与血栓栓塞风险之间具有密切的关系。目前,CS患者的二级预防是临床关注的重点,尤其是抗栓药物的选择。 Paroxysmal atrial fibrillation(PAF) is the most common cardiac risk factor of cryptogenic stroke(CS). As the improvement of electrocardiogram detecting technology, newer cardiac monitoring devices, such as the remote dynamic ECG monitors,insertable cardiac monitors, pacemakers and implantable cardioverter-defibrillators, continue to improve our ability to detect PAF, and increase the detection rate of PAF. Some simple practical clinical scoring methods offer an auxiliary method for the diagnosis of PAF. In addition, the duration and the frequency of atrial fibrillation has a close relationship with the risk of thromboembolism. The major challenge in managing CS is secondary stroke prevention, especifically in choosing antithrombotic therapy.
出处 《医学综述》 2017年第9期1791-1795,共5页 Medical Recapitulate
基金 湖北省卫生计生西医类重点项目(WJ2015MA007) 武汉市应用基础研究计划项目(2015060101010047)
关键词 隐源性脑卒中 阵发性心房颤动 筛查 Paroxysmal atrial fibrillation Cryptogenic stroke Screening
  • 相关文献

参考文献2

二级参考文献101

  • 1秦俭(编译),赵妍(编译).胆固醇水平与出血性脑卒中发病的人群差别:血清胆固醇与出血性脑卒中、缺血性脑卒中及心肌梗死:韩国国家卫生系统前瞻性队列研究[J].世界急危重病医学杂志,2006,3(4):1397-1400. 被引量:43
  • 2Wahlgren N, Ahrced N, Davalos A, et al; SITS-MOST Investigators. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITSMOST): an observational study. Lancet, 2007, 369: 275-282. 被引量:1
  • 3Lyden PD, ed. Thrombolytic Therapy for Acute Stroke. 2nd ed. Totowa, NJ: Hmreana Press, 2005. 被引量:1
  • 4Wardlaw JM, Smdercock PA, Berg: E. Throrrbolytic therapy with recoinbinant tissue plasminogen activator for acute ischemic stroke: where do we go from here? A cunaflative meta-analysis. Stroke, 2003, 34: 1437-1442. 被引量:1
  • 5Wardlaw JM, Zoppo G, Yamaguchi T, et al. Thrombolysis for acute ischaemic stroke. Cochrane Database Syst Rev, 2003, (4): CD000213. 被引量:1
  • 6Shanna M, Clark H, Armour T, et al. Acute stroke: evaluation and treatment. Evid Rep Technol Assess (Sunmm), 2005, (127): 1-7. 被引量:1
  • 7Hill MD, Buchan AM; Canadian Alteplase for Stroke Effectiveness Study (CASES) Investigators. Throrrbolysis for acute ischemic stroke: results of the Canadian Altephse for Stroke Effectiveness Study. CMAJ, 20(0, 172: 1307-1312. 被引量:1
  • 8Chung H, Refoios Canto R, Canto RR, et al. Alteplase for the treatment of acute ischaemic stroke: NICE technology appraisal guidance. Heart, 2007, 93: 1616-1617. 被引量:1
  • 9Saver JL, Smith EE, Fonarow GC, et al; GWTG-stroke Steering Committee and Investigators. The "golden hour" and acute brain ischemia: presenting features and lytic therapy in > 30,000 patients ariving within 60 minutes of stroke onset. Stroke, 2010, 41: 1431-1439. 被引量:1
  • 10Scott PA, Xu Z, Meurer WJ, et al. Attitudes and beliefs of Michigan emergmcy physicians toward tissue plasminogen activator use in stroke: baseline survey results from the INcreasing Stroke Treatment through INteractive behavioral Change Tactic (INSTINCT) trial hospitals. Stroke, 2010, 41: 2026-2032. 被引量:1

共引文献1372

同被引文献9

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部